Synopsis：Lenalidomide (also known as ralidomide) has been successfully used in the treatment of inflammatory diseases and cancer. The indications approved by FDA are: combined with dexamethasone in the treatment of multiple myelochemical Book tumor (mm); As maintenance therapy for mm after autologous hematopoietic stem cell transplantation. However, what many patients do not know is that it can also be used in hepatocellular carcinoma.
Structural formula:
Properties
Summary
Lenalidomide (also known as ralidomide) has been successfully used in the treatment of inflammatory diseases and cancer. The indications approved by FDA are: combined with dexamethasone in the treatment of multiple myelochemical Book tumor (mm); As maintenance therapy for mm after autologous hematopoietic stem cell transplantation. However, what many patients do not know is that it can also be used in hepatocellular carcinoma.
Manufacturing
